Search clinical trials for: 1% atorvastatin calcium salt ointment

Total 1444 results

Nicolaus Copernicus University

Completed

The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (EVRAAS)

Non-segmental Vitiligo

Poland
Lesaffre International
BioFortis; Soladis

Terminated

Bioavailability Study of Folate in Healthy Subjects

Healthy

France
PharmaEssentia
PharmaEssentia Japan K.K.

Completed

Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

Healthy Volunteer

Japan
Pfizer

Completed

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

Dermatitis, Atopic

Australia
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

Meibomian Gland Dysfunction | MGD-Meibomian Gland Dysfunction

United States
PharmaEssentia
PharmaEssentia Japan K.K.

Completed

A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp

Actinic Keratosis

Japan
Ziarco Pharma Ltd

Completed

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

Atopic Dermatitis

United Kingdom
GlaxoSmithKline

Completed

Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)

Skin Infections, Bacterial

United States, South Africa, India, Argentina, Brazil
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
Technoderma Medicines Inc.
Therapeutics, Inc.

Recruiting

Study of TDM-180935 in Atopic Dermatitis Patients

Atopic Dermatitis

United States
Medimetriks Pharmaceuticals, Inc

Completed

Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis

Atopic Dermatitis

United States, Honduras, Panama
GlaxoSmithKline

Completed

Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo

Skin Infections, Bacterial

Netherlands, Costa Rica, Germany, Mexico, Canada, India, Poland, South Africa, France, Peru
Oneness Biotech Co., Ltd.

Completed

The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers

Diabetic Foot

Taiwan
GlaxoSmithKline

Completed

Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.

Skin Infections, Bacterial

United States, Germany, Taiwan, Netherlands, Argentina, Chile, Costa Rica, South Africa, Mexico
GlaxoSmithKline

Completed

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

Impetigo

India, Mexico, Netherlands, Italy, Peru
Austin Institute for Clinical Research

Recruiting

Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

Superficial Basal Cell Carcinoma

United States
DermaGen AB

Completed

A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060

Atopic Dermatitis

Sweden
Circassia Limited
Bioskin GmbH

Completed

Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Atopic Dermatitis (AD)

China
Dong-A University Hospital

Completed

Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects

Colorectal Cancer | Pancreatic Cancer | Non-small Cell Lung Cancer

Korea, Republic of
Castle Creek Pharmaceuticals, LLC

Terminated

Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)

Epidermolysis Bullosa Simplex

United States, Israel, Australia, Austria, France, Germany, Netherlands, United Kingdom
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

Mild to Moderate Atopic Dermatitis
LEO Pharma

Completed

A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris

Psoriasis Vulgaris

France
Pfizer

Completed

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Hyperlipidemia

United States, Germany, Norway, Belgium, Korea, Republic of, Mexico, Sweden, United Kingdom
LEO Pharma

Completed

An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris

Psoriasis Vulgaris

France
Sichuan Provincial People's Hospital
Science & Technology Department of Sichuan Province

Not yet recruiting

Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds

Acute Ischemic Stroke | Cerebral Microbleeds

China
Merck Sharp & Dohme LLC

Completed

Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)

Mixed Dyslipidemia | Primary Hypercholesterolemia
Novartis Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients

Erythemato-telangiectatic Rosacea

United States
Southwest Autism Research & Resource Center
United States Department of Defense; State University of New York - Downstate...

Recruiting

Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium

Autism Spectrum Disorder | Language Disorders

United States
Southwest Autism Research & Resource Center
Autism Speaks; State University of New York - Downstate Medical Center

Recruiting

Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism

Autism Spectrum Disorder | Language Disorders

United States
LEO Pharma

Completed

A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris

Psoriasis Vulgaris

France
Merck Sharp & Dohme LLC

Completed

A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)

Hypercholesterolemia
Pfizer

Completed

CP-690-550 Ointment For Chronic Plaque Psoriasis

Psoriasis

United States, Canada
Hospital Universitari Vall d'Hebron Research Institute

Unknown

Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males (TreatAIN)

High-grade Anal Intraepithelial Neoplasia
Emory University
Georgia Center for Oncology Research & Education

Not yet recruiting

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

Human Immunodeficiency Virus | Human Papilloma Virus | Anal Intraepithelial Neoplasia | High-Grade Squamous Intraepithelial Lesions

United States
Centre Hospitalier Universitaire de Nice

Recruiting

sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia (PROSPE)

Pre-Eclampsia

France
University of Oklahoma

Not yet recruiting

CBD Effects on Forehead Split Scar Healing

Forehead; Wound
NewAmsterdam Pharma
Pharma Medica Research, Inc.

Completed

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

Healthy Volunteers

Canada
Shandong University

Not yet recruiting

Atorvastatin in Management of Newly Diagnosed ITP

Purpura, Thrombocytopenic | Immune Thrombocytopenia

China
Assistance Publique - Hôpitaux de Paris

Completed

MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study (MOMA)

Hypertension | Pregnancy | Preeclampsia | Intrauterine Growth Retardation | Primiparity

France
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Dyslipidemia
Columbia University
National Institute of Allergy and Infectious Diseases (NIAID); GlaxoSmithKline

Completed

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection

HIV Infections | Staphylococcus Aureus

United States
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds

Psoriasis Vulgaris

United Kingdom, France, Canada
Assistance Publique - Hôpitaux de Paris
INSERM CESP1018

Completed

Preeclampsia Ratio (sFlt-1/PlGF) (PRECOG)

Preeclampsia

France
Philip Binkley
Pfizer

Completed

Statin Therapy for Ischemic and Nonischemic Cardiomyopathy

Myocardial Ischemia | Cardiovascular Disease | Heart Disease | Cardiomyopathy | Myocardial Disease

United States
NovaBay Pharmaceuticals, Inc.
Novum Pharmaceutical Research Services; International Dermatology Research,...

Completed

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Impetigo

Dominican Republic
AstraZeneca

Completed

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

Acute Coronary Syndromes

United States, Costa Rica, Panama, El Salvador, Morocco
Petteri Hirvonen
University of Jyvaskyla

Completed

Novel Energy Metabolic Signaling Molecule With Therapeutic Potential (RH013001)

Healthy Participants

Finland

Search clinical trials for: 1% atorvastatin calcium salt ointment

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations